Substance P increases neutrophil adhesion to human umbilical vein endothelial cells
about
Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitisThe role of histamine in neurogenic inflammationCellular and molecular mechanisms in environmental and occupational inhalation toxicologyRosiglitazone and AS601245 decrease cell adhesion and migration through modulation of specific gene expression in human colon cancer cellsContributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis.Multiple Phenotypic Changes Define Neutrophil PrimingSubstance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cellsWithout nerves, immunology remains incomplete -in vivo veritas.Activation of the neurokinin-1 receptor by substance P triggers the release of substance P from cultured adult rat dorsal root ganglion neuronsCelecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29).Electronic cigarette exposure triggers neutrophil inflammatory responses.Plasma urotensin II and neurokinin B levels in acute myocardial infarction and stable coronary artery disease.The role of substance p in ischaemic brain injury.Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.Tachykinin receptor modulation of cyclooxygenase-2 expression in human polymorphonuclear leucocytes.Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells.Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study.The impact of substance P signalling on the development of experimental staphylococcal sepsis and arthritis.Hormesis: its impact on medicine and health.Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity.Evaluation of in-vitro anti-inflammatory activity of some 2-alkyl-4,6-dimethoxy-1,3,5-triazines.Substance P initiates NFAT-dependent gene expression in spinal neurons.
P2860
Q24656280-B3A4B962-0607-4BD8-8B2C-694E73A986BFQ26993211-9FFE3F85-B709-4AEC-945C-A3106A3DD325Q28392962-995A1100-91FA-4E78-B9AC-B92868D881EFQ28727835-390A98C8-EACA-4A74-B7E0-D190B04C7DCEQ30442772-1FA01CCA-5D40-483E-8FD0-95E5709193E1Q33734931-FD7EAD75-F810-4F5E-88D0-EEEC7D0DBC72Q35545383-19B6F1CB-766B-407C-85EA-36D57D598D20Q36257285-21EB3029-D65C-4E83-AB27-C5B717903DECQ36449385-978726CC-6C74-450E-AE9C-9FF13237C38FQ36495162-BFCF14F3-79F0-440E-A15D-4B3B07345589Q36907377-D4A7866F-9C9A-4983-B7BD-D541DC62ED7BQ37680436-30AFFADC-FFE1-4B62-BE62-2D251457724DQ38222871-8C753B50-980F-40DB-85FF-60AE47B82BDEQ40034818-DF82A673-BA7B-44B4-934B-3E58A422003CQ41429366-B743FF69-2D83-4476-8047-4E2FCBD4A353Q41779474-9027BF26-EB14-4004-BEE3-D1548170ADF7Q42200349-5D6837F0-5086-431A-A02E-4EC7D1B3709FQ44478868-620901C4-8AC8-4E1B-B369-D33344C2EA01Q44693677-5DA0AE7D-1FCB-4199-B5D3-923C723843AFQ45976740-5CFBD0D3-41EF-4B4E-AA8C-F51463FD44C1Q46922955-F53F883D-9B29-4173-8705-9A9ADEF25119Q48617592-7DCD5484-93CD-4FF0-BAAE-E39B6298D50B
P2860
Substance P increases neutrophil adhesion to human umbilical vein endothelial cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Substance P increases neutrophil adhesion to human umbilical vein endothelial cells
@en
type
label
Substance P increases neutrophil adhesion to human umbilical vein endothelial cells
@en
prefLabel
Substance P increases neutrophil adhesion to human umbilical vein endothelial cells
@en
P2093
P2860
P356
P1476
Substance P increases neutrophil adhesion to human umbilical vein endothelial cells
@en
P2093
Chiara Dianzani
Giovanni Garbarino
Grazia Lombardi
Massimo Collino
Roberto Fantozzi
P2860
P304
P356
10.1038/SJ.BJP.0705344
P407
P577
2003-07-01T00:00:00Z